Angiogenesis in the human corpus luteum of the normal menstrual cycle and during early pregnancy;Angiogenese im corpus luteum des menstruellen zyklus und der frühgravidität

Geburtshilfe und Frauenheilkunde

Volumn 64, Issue 7, 2004, Pages 690-699

  Wulff, Christine ^a   Fraser, H M ^b   Kreienberg, R ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Angiogenesis; Corpus luteum; Gonadotrophin; VEGF (vascular endothelial growth factor)

Indexed keywords

ANGIOPOIETIN RECEPTOR; ANGIOTENSIN; ANGIOTENSIN I; CD31 ANTIGEN; CD34 ANTIGEN; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; KI 67 ANTIGEN; LUTEINIZING HORMONE; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; CAPILLARY; CELL PROLIFERATION; CORPUS LUTEUM; HORMONAL REGULATION; HUMAN; MENSTRUAL CYCLE; PREGNANCY; REVIEW; VASCULAR ENDOTHELIUM;

EID: 3242685195     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-820858     Document Type: Review

References (56)

1. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48-50
2. Fraser HM, Lunn SF. Angiogenesis and its control in the female reproductive system. British Med Bull 2000; 56: 787-797
3. Fraser HM, Wulff C. Angiogenesis in the primate ovary. Reproduction, Fertil Development 2001; 13: 557-566
4. Illingworth PJ, Reddi K, Smith K, Baird DT. Pharmacologic "rescue" of the corpus luteum results in increased inhibin production. Clin Endocrinol 1990; 33: 323-332
5. Suzuki T, Sasano H, TaKaya R, Fukaya T, Yajima A, Nagura H. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod 1998; 13: 953-959
6. A40) in the primate. Endocrinology 2001; 142: 3244-3254
7. Zeleznik AJ, Schuleer HM, Reichert JRLE. Gonadotropin-binding sites in the rhesus monkey ovary: Role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 1981; 109: 356-362
8. Tsukada K, Matsushima T, Yamanaka N. Neovascularization of the corpus luteum of rats during the estrus cycle. Pathology Int 1996; 46: 408-416
9. Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W. Ovarian angiogenesis: Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 1995; 147: 339-351
10. Rodger FE, Young FM, Fraser HM, Illingworth PJ. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum Reprod 1997; 12: 1723-1729
11. Christenson LK, Stouffer RL. Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. Endocrinology 1996; 137: 367-374
12. Young FM, Rodger FE, Illingworth PJ, Fraser HM. Cell proliferation and vascular morphology in the marmoset corpus luteum. Hum Reprod 2000; 15: 557-566
13. Wulff C, Dickson SE, Duncan WC, Fraser HM. Angiogenesis in the human corpus luteum: Simulating early pregnancy by hCG treatment is associated with both angiogenesis and vessel stabilisation. Hum Reprod 2001; 16: 2515-2524
14. Jablonka-Shariff A, Grazul-Bilska AT, Redmer DA, Reynolds LP. Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle. Endocrinology 1993; 133: 1871-1879
15. Zheng J, Fricke PM, Reynolds LP, Redmer DA. Evaluation of growth, cell proliferation, and cell death in bovine corpora lutea throughout the estrous cycle. Biol Reprod 1994; 51: 623-632
16. Al-Zi'abi MO, Watson ED, Fraser HM. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum. Reproduction 2003; 125: 259-270
17. Dickson SE, Fraser HM. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate. J Clin Endocrinol Metab 2000; 85: 2339-2344
18. Gaytan F, Morales C, Garcia-Pardo L, Reymundo C, Bellido C, Sanchez-Criado J. Macrophages, cell proliferation, and cell death in the human menstrual corpus luteum. Biol Reprod 1998; 59: 417-425
19. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Laboratory Invest 1998; 78: 1385-1394
20. Redmer DA, Doraiswamy V, Bortnem BJ et al. Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol Reprod 2001; 65: 879-889
21. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999; 13: 1055-1066
22. Shalaby F, Rossant J, Yamaguchi TP et al. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 1995; 376: 62-66
23. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66-70
24. Sato E. Microvasculature in the mouse ovarian follicle demonstrated by a lectin angiography method. Italian J Anatomy 1995, 100 (Suppl 1): 461-467
25. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439
26. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91: 2235-2243
27. Sharkey AM, Charnock-jones DS, Boocock CA, Brown KD, Smith SK. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 1993; 99: 609-615
28. Phillips HS, Hains J, Leung DW, Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 1990; 127: 965-967
29. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996; 81: 353-359
30. Otani N, Sawako M, Yamoto M et al. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab 1999; 84: 3845-3851
31. Hazzard TM, Christenson LK, Stouffer RL. Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle. Mol Hum Reprod 2000; 6: 993-998
32. Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG, Fraser HM. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, Tie-2 and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 2000; 85: 4302-4309
33. Fraser HM, Wulff C, Wiegand SJ, Rudge JS. Inhibition of vascular endothelial growth factor action in the primate reproductive system. Biol Reprod 2002; 66 (Suppl 1): 82
34. A40. J Clin Endocrinol Metab 2001; 86: 3377-3386
35. Davis S, Aldrich TH, Jones PF et al. Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169
36. Suri C, Jones P, Patan S et al. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor during embryonic angiogenesis. Cell 1996; 87: 1171-1180
37. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60
38. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznik AJ. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 1992; 131: 254-260
39. Redmer DA, Dai Y, Li J et al. Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum. J Reprod Fertil 1996; 108: 157-165
40. Ravindranath N, Selvaraj N, Moudgal NR. Effects of selective deprivation of FSH and LH on follicular maturation in the bonnet monkey (Macaca radiata). In: Moudgal NR, Yoshinaga K, Rao AJ, Adiga PR (eds). Perspectives in Primate Reproductive Biology. 1 ed. New Delhi: Wiley Eastern Limited, 1991: 13-21
41. Christenson LK, Stouffer RL. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J Clin Endocrinol Metab 1997; 82: 2135-2142
42. Neulen J, Raczek S, Pogorzelski M et al. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol Hum Reprod 1998; 4: 203-206
43. Zygmunt M, Herr F, Keller-Schoenwetter S et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002; 87: 5290-5296
44. Neulen J, Yan ZP, Raczek S et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995; 80: 1967-1971
45. Rowe AJ, Morris KD, Bicknell R, Fraser HM. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy. Biol Reprod 2002; 67: 1180-1188
46. Gaytan F, Morales C, Garcia-Pardo L et al. A quantitative study of changes in the human corpus luteum microvasculature during the menstrual cycle. Biol Reprod 1999; 60: 914-919
47. Wiegand SJ, Boland P, Yancopoulos GD. Cooperative roles for the angiopoietins and vascular endothelial growth factor in ovarian angiogenesis. In: Adashi EY (ed). Ovulation: Evolving Scientific and Clinical Concepts. New York: Springer-Verlag, 2000: 175-186
48. Findlay JK. Angiogenesis in reproductive tissues. J Endocrinol 1986; 111: 357-366
49. Folkman J. Angiogenesis in female reproductive organs. In: Alexander NJ, D'Arcangues C (eds). Steroid Hormones and Uterine Bleeding. Washington DC: AAAS Press, 1992: 143-158
50. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB Journal 1992; 6: 886-892
51. Fraser HM, Dickson SE, Lunn SF et al. Suppression of luteal angiogenesis in the primate by neutralization of vascular endothelial growth factor. Endocrinology 2000; 141: 995-1000
52. Ferrara N, Chen H, Davis-Smyth T et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med 1998; 4: 336-340
53. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM. Prevention of thecal angiogenesis, antral follicular growth and ovulation in the primate by treatment with endothelial growth factor trap R1R2. Endocrinology 2002; 143: 2797-2807
54. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Am J Pathol 1995; 146: 157-165
55. Lee A, Burry KA, Christensen LK, Patton PE, Stouffer RL. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 1997; 68: 305-311
56. Gescher DM, Meyhöfer-Malik A, Rath W, Malik E. mRNA-Expression von Angiopoietin-1 und -2 im ektopen Endometrium auf der Chorioallantoismembran (CAM). Geburtsh Frauenheilk 2003; 63: 1279-1283